Cargando…

Reduced Expression of Annexin A6 Induces Metabolic Reprogramming That Favors Rapid Fatty Acid Oxidation in Triple-Negative Breast Cancer Cells

SIMPLE SUMMARY: The expression status of Annexin A6 (AnxA6) has been shown to influence tumor growth, metastasis, and resistance to therapeutic intervention, but the contribution of this tumor suppressor in the metabolic adaptation of basal-like (AnxA6-low) versus mesenchymal-like (AnxA6-high) TNBC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Stephen D., Sakwe, Amos M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909273/ https://www.ncbi.nlm.nih.gov/pubmed/35267416 http://dx.doi.org/10.3390/cancers14051108

Ejemplares similares

Hypoxia-Inducible Expression of Annexin A6 Enhances the Resistance of Triple-Negative Breast Cancer Cells to EGFR and AR Antagonists
por: Williams, Stephen D., et al.
Publicado: (2022)

Diverse Roles of Annexin A6 in Triple-Negative Breast Cancer Diagnosis, Prognosis and EGFR-Targeted Therapies
por: Korolkova, Olga Y., et al.
Publicado: (2020)

Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets
por: Korolkova, Olga Y., et al.
Publicado: (2020)

Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors
por: Widatalla, Sarrah E, et al.
Publicado: (2019)

Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility
por: Whalen, Diva S., et al.
Publicado: (2019)

Reduced annexin A6 expression promotes the degradation of activated epidermal growth factor receptor and sensitizes invasive breast cancer cells to EGFR-targeted tyrosine kinase inhibitors
por: Koumangoye, Rainelli B, et al.
Publicado: (2013)

Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

Metabolic reprogramming in triple-negative breast cancer
por: Wang, Zhanyu, et al.
Publicado: (2020)

Identification of MAGEC2/CT10 as a High Calcium-Inducible Gene in Triple-Negative Breast Cancer
por: Beasley, Heather K., et al.
Publicado: (2022)

Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer
por: Li, Ting, et al.
Publicado: (2021)

MIG‐6 is essential for promoting glucose metabolic reprogramming and tumor growth in triple‐negative breast cancer
por: He, Jiabei, et al.
Publicado: (2021)

Myc derived circRNA promotes triple-negative breast cancer progression via reprogramming fatty acid metabolism
por: Wang, Shengting, et al.
Publicado: (2023)

Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer
por: Iorio, Egidio, et al.
Publicado: (2016)

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Munkácsy, Gyöngyi, et al.
Publicado: (2023)

A Cell-Based Systematic Review on the Role of Annexin A1 in Triple-Negative Breast Cancers
por: Pearanpan, Lishantini, et al.
Publicado: (2022)

Inhibition of 6-Phosphogluconate Dehydrogenase Reverses Epirubicin Resistance Through Metabolic Reprograming in Triple-Negative Breast Cancer Cells
por: Xu, Jiali, et al.
Publicado: (2023)

The Role of Fatty Acid Oxidation in the Metabolic Reprograming of Activated T-Cells
por: Byersdorfer, Craig Alan
Publicado: (2014)

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

Zinc Favors Triple-Negative Breast Cancer’s Microenvironment Modulation and Cell Plasticity
por: Vogel-González, Marina, et al.
Publicado: (2021)

Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies
por: Chaudhary, P, et al.
Publicado: (2014)

Inhibition of Triple-Negative Breast Cancer Cell Aggressiveness by Cathepsin D Blockage: Role of Annexin A1
por: Zóia, Mariana Alves Pereira, et al.
Publicado: (2019)

Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis
por: Chaudhary, Pankaj, et al.
Publicado: (2020)

The annexins
por: Moss, Stephen E, et al.
Publicado: (2004)

Short term starvation potentiates the efficacy of chemotherapy in triple negative breast cancer via metabolic reprogramming
por: Pateras, Ioannis S., et al.
Publicado: (2023)

MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
por: Goode, Gennifer, et al.
Publicado: (2017)

Regulation of Mitochondrial Morphogenesis by Annexin A6
por: Chlystun, Marcin, et al.
Publicado: (2013)

Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer
por: O’Flanagan, Ciara H., et al.
Publicado: (2017)

Correction to: Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis
por: Chaudhary, Pankaj, et al.
Publicado: (2020)

Interleukin-6 Signaling in Triple Negative Breast Cancer Cells Elicits the Annexin A1/Formyl Peptide Receptor 1 Axis and Affects the Tumor Microenvironment
por: Vecchi, Lara, et al.
Publicado: (2022)

Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
por: Goode, Gennifer, et al.
Publicado: (2017)

TGF-β induced reprogramming and drug resistance in triple-negative breast cells
por: Wu, Guoyu, et al.
Publicado: (2022)

Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer
por: Poddar, Arpita, et al.
Publicado: (2022)

Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis
por: Okano, Maiko, et al.
Publicado: (2019)

Androgen receptor expression identifies patient with favorable outcome in operable triple negative breast cancer
por: Hu, Xiao-Qing, et al.
Publicado: (2017)

VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer
por: Cao, Xi, et al.
Publicado: (2021)

Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
por: Camarda, Roman, et al.
Publicado: (2016)

The antioxidant response favors Leishmania parasites survival, limits inflammation and reprograms the host cell metabolism
por: Reverte, Marta, et al.
Publicado: (2021)

Reprogramming of fatty acid metabolism in cancer
por: Koundouros, Nikos, et al.
Publicado: (2019)

The rapid endocytic uptake of fetuin‐A by adherent tumor cells is mediated by Toll‐like receptor 4 (TLR4)
por: Thomas, Portia L., et al.
Publicado: (2020)

Heparin Prowess: Favorable Vascular–Immune Reprogramming in Pancreatic Cancer
por: Korc, Murray
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4rbl054mdmirqs4iinegdruif3